Publications by authors named "Marta Lorda-Espes"
Article Synopsis
- The study examines the use of guselkumab for treating psoriasis in patients with a history of cancer, addressing the limited guidance available for such cases.
- A total of 20 patients were followed over 52 weeks, with high effectiveness rates seen (87.5% achieving a low psoriasis severity score) and a 100% survival rate, including those with active cancers.
- The findings suggest guselkumab is both effective and safe in this population, though the study is limited by its small sample size and retrospective design.*
Essential thrombocythemia is a chronic myeloproliferative syndrome which usually runs its course as an asymptomatic elevated platelet count. Cutaneous manifestations secondary to microcirculation abnormalities are rare but can represent a helpful diagnostic clue in order to prevent major thromboembolic events. We report two cases of heterogeneous livedoid and "net-like" skin lesions in the context of essential thrombocythemia with identical histopathologic findings (medium-sized blood vessels with luminal obliteration by eosinophilic material, mostly positive for the platelet marker CD61, without vasculitis).
View Article and Find Full Text PDFBlack spots and skin rash with fever in hunting preserve worker.
Enferm Infecc Microbiol Clin (Engl Ed)
February 2021